The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Peter James

Peter James

Professor

Peter James

Large-Scale Proteomics Analysis of Human Ovarian Cancer for Biomarkers

Author

  • S Bengtsson
  • Morten Krogh
  • C Al-Khalili Szigyarto
  • M Uhlen
  • K Schedvins
  • C Silfversward
  • S Linder
  • G Auer
  • A Alaiya
  • Peter James

Summary, in English

Ovarian cancer is usually found at a late stage when the prognosis is often bad. Relative survival rates decrease with tumor stage or grade, and the 5-year survival rate for women with carcinoma is only 38%. Thus, there is a great need to find biomarkers that can be used to carry out routine screening, especially in high-risk patient groups. Here, we present a large-scale study of 64 tissue samples taken from patients at all stages and show that we can identify statistically valid markers using nonsupervised methods that distinguish between normal, benign, borderline, and malignant tissue. We have identified 217 of the significantly changing protein spots. We are expressing and raising antibodies to 35 of these. Currently, we have validated 5 of these antibodies for use in immunohistochemical analysis using tissue microarrays of healthy and diseased ovarian, as well as other, human tissues.

Department/s

  • Computational Biology and Biological Physics - Undergoing reorganization
  • Department of Immunotechnology

Publishing year

2007

Language

English

Pages

1440-1450

Publication/Series

Journal of Proteome Research

Volume

6

Issue

4

Document type

Journal article

Publisher

The American Chemical Society (ACS)

Topic

  • Immunology in the medical area
  • Biophysics

Status

Published

ISBN/ISSN/Other

  • ISSN: 1535-3893